Oyticker
LIVE
  1. Live market news
  2. Stocks
  3. NKTR

Nektar Therapeutics

NKTRStockUnited States

36.15USD−2.33 (−6.06%)Live · 5 Nov, 20:59 UTC
See in Charts
About

Nektar Therapeutics

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.

Key figures

Previous close
38.48
Open
38.36
Day range
35.76 – 38.36
52-week range
—
Volume
708K

In detailthe same figures as in Oyticker Charts

Performance

1D−6.1%

Ranges & volume

Day35.76 – 38.36
52 weeks—
Open
38.36
Prev. close
38.48
Volume 708Kavg —

Risk · 1 year

Not enough historyRisk needs at least a month of daily sessions.

Seasonality

Not enough historySeasonality needs several months of data.
SEC filings

What NKTR filed

All its filings

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.